The Journal of clinical endocrinology and metabolism · 2025
The Value of LC-MS/MS in Apparent Bilateral Aldosterone Suppression in Adrenal Venous Sampling for Primary Aldosteronism.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Li Wei, Zhou Qixin, He Yifan, He Wenwen, Song Ying, Hu Jinbo, Wang Yue, Luo Ting, Li Qifu, Yang Shumin
Аннотация
CONTEXT: Adrenal venous sampling (AVS) is recommended for subtyping primary aldosteronism (PA); however, it is unreliable when apparent bilateral aldosterone suppression (ABAS) occurs, defined as aldosterone/cortisol ratio in the adrenal vein being bilaterally lower than that in the inferior vena cava. The value of liquid chromatography-tandem mass spectrometry (LC-MS/MS) in PA subtyping when ABAS occurs is unclear.
OBJECTIVE: This work aimed to determine whether LC-MS/MS can reduce the occurrence of ABAS and misdiagnosis of PA subtyping.
METHODS: Aldosterone and cortisol in AVS samples from 219 patients with PA were measured by LC-MS/MS and immunoassay (IA). Then ABAS occurrence and misdiagnosis rate of PA subtyping were calculated.
RESULTS: Among 219 patients with PA, 111 and 60 received nonadrenocorticotropin (non-ACTH) and ACTH-stimulated AVS, respectively, and 48 received both. In unstimulated AVS, LC-MS/MS reduced the ABAS occurrence compared to IA (10.7% [17/159] vs 3.1% [5/159]). Among 159 patients with unstimulated AVS, there were 77 patients who had final subtyping diagnosis based on postoperative outcomes. The misdiagnosis rate of IA and LC-MS/MS was 10.4% (8/77) and 9.1% (7/77), respectively. However, misdiagnosis was more common in patients with ABAS than in those without ABAS. For IA, 5 out of 6 ABAS patients were misdiagnosed, while 3/71 non-ABAS patients were misdiagnosed. For LC MS/MS, only one ABAS patient had follow-up outcome and he was misdiagnosed, while 6 of 76 non-ABAS patients were misdiagnosed. Similar results were found in ACTH-stimulated AVS.
CONCLUSION: LC-MS/MS measurement of aldosterone and cortisol is a new resolution when ABAS occurs.
OBJECTIVE: This work aimed to determine whether LC-MS/MS can reduce the occurrence of ABAS and misdiagnosis of PA subtyping.
METHODS: Aldosterone and cortisol in AVS samples from 219 patients with PA were measured by LC-MS/MS and immunoassay (IA). Then ABAS occurrence and misdiagnosis rate of PA subtyping were calculated.
RESULTS: Among 219 patients with PA, 111 and 60 received nonadrenocorticotropin (non-ACTH) and ACTH-stimulated AVS, respectively, and 48 received both. In unstimulated AVS, LC-MS/MS reduced the ABAS occurrence compared to IA (10.7% [17/159] vs 3.1% [5/159]). Among 159 patients with unstimulated AVS, there were 77 patients who had final subtyping diagnosis based on postoperative outcomes. The misdiagnosis rate of IA and LC-MS/MS was 10.4% (8/77) and 9.1% (7/77), respectively. However, misdiagnosis was more common in patients with ABAS than in those without ABAS. For IA, 5 out of 6 ABAS patients were misdiagnosed, while 3/71 non-ABAS patients were misdiagnosed. For LC MS/MS, only one ABAS patient had follow-up outcome and he was misdiagnosed, while 6 of 76 non-ABAS patients were misdiagnosed. Similar results were found in ACTH-stimulated AVS.
CONCLUSION: LC-MS/MS measurement of aldosterone and cortisol is a new resolution when ABAS occurs.